We developed a system for complete replication of encephalomyocarditis virus (EMCV) in a test tube by using an in vitro translation extract from Krebs-2 cells. Efficient virus synthesis occurred in a narrow range of Mg 2؉ and EMCV RNA concentrations. Excess input RNA impaired RNA replication and virus production but not translation. This suggests the existence of a negative-feedback mechanism for regulation of RNA replication by the viral plus-strand RNA or proteins.
1 mM dithiothreitol), allowed to swell on ice for 20 min, and lysed with ϳ30 strokes of a tightly fitting Dounce homogenizer (Kontes). Concentrated buffer solution (1/9 volume; 25 mM HEPES-KOH [pH 7.3], 1 M KCH 3 COO, 30 mM MgCl 2 , 30 mM dithiothreitol) was then added, and the homogenate was centrifuged at 18,000 ϫ g for 20 min at 4°C. The supernatant (35 to 45 A 260 U per ml) was stored at Ϫ70°C. Before translation, the extract was treated with micrococcal nuclease (150 U/ml; Roche) essentially as described previously (32) . EMCV (K2) RNA was extracted from the purified virus (34) . Translation reaction mixtures (50 l) contained 25 l (50% by volume) of S10, 5 l of a master mix (10 mM ATP, 2 mM GTP, 2 mM CTP, 2 mM UTP, 100 mM creatine phosphate [dipotassium salt], 1 mg of rabbit muscle creatine phosphokinase 35 S]methionine (10 mCi/ml [Ͼ1,000 Ci/mmol]), and EMCV RNA (2 to 30 g/ml). Translation was at 32 to 33°C for the times indicated in the figure legends. Proteins were analyzed by sodium dodecyl sulfate-15% polyacrylamide gel electrophoresis (SDS-15% PAGE) and autoradiography. RNA replication and virion production were assayed in similarly programmed reactions, except that unlabeled 0.4 mM L-methionine was substituted for [ 35 S]methionine in the reaction cocktail.
In agreement with previous data (32), translation of EMCV RNA in Krebs-2 S10 yielded all the known virus proteins (Fig.  1A) . A time course of the appearance of L-P1-2A (the Nterminal portion of the viral polyprotein), 2C (the central portion), and P3 (the C-terminal portion) was consistent with the complete translation of the viral genome over 0.5 h of incubation time. During the subsequent incubation, the L-P1-2A and P3 polypeptides were cleaved and the mature viral structural and nonstructural proteins appeared. The magnesium concentration range for optimum translation was relatively broad, and variations within the 2 to 4 mM concentration range did not significantly affect labeling or the pattern of the products. Polypeptide synthesis was EMCV RNA dose dependent (Fig.  1B) . Thus, Krebs-2 S10 prepared by the method described translates EMCV RNA efficiently and accurately.
In vitro translation of EMCV RNA yields, among other viral proteins, high amounts of the RNA-dependent RNA polymerase 3D pol (Fig. 1) . To demonstrate that 3D pol (in combination with other factors) supports RNA replication, we pulse-labeled the reaction mixtures with [␣-32 P]CTP at different times after the beginning of incubation. The newly synthesized RNA was extracted and quantified after trichloroacetic acid precipitation. RNA synthesis was first detectable at ϳ2 h and reached a maximum at 4 to 5 h of incubation ( Fig. 2A) . On the other hand, pulse-labeling of reaction mixtures with [ 35 S]methionine during the same time course revealed a maximum rate of viral translation at ϳ1 h of incubation. By the time of maximal RNA synthesis (4 h), the rate of virus translation had declined dramatically (to less than 5% of the maximal rate level). Thus, our in vitro system recapitulates the switch from viral translation to RNA replication characteristic of many picornavirus systems in vivo (12) . The major RNA product comigrated with the fulllength EMCV RNA in an agarose gel (Fig. 2B) . To examine the possibility that this product results from labeling of the input RNA by 3D pol -associated terminal nucleotidyltransferase activity (29), we performed its digestion with RNase T1. This digestion, similarly to that of virion RNA (8, 35) , liberated a large (ϳ150-nucleotide) poly(C) tract-containing fragment (data not shown). This strongly suggests that the vast majority of the in vitro product was uniformly labeled and was represented by the newly synthesized plus-strand RNA. It is noteworthy that small amounts of slowly migrating RNA species were generated in EMCV RNA-programmed but not in mockprogrammed reactions (Fig. 2B ). This product comigrates with the double-stranded replicative-form RNA (3). The propensity of the system for the synthesis of plus-strand RNA accords well with the known asymmetry of picornaviral replication in vivo, where the ratio of newly synthesized positive-to negativestrand RNAs is 30 to 70:1 (13, 24) . Efficient RNA synthesis required Mg 2ϩ in a narrow (3 to 3.5 mM) range of concentrations (Fig. 2C) , in sharp contrast to the broad range observed for translation. Lowering the magnesium salt concentration to 2 mM resulted in almost no RNA synthesis (Fig. 2C ) while causing only marginal inhibition of translation (data not shown). An EMCV RNA dose-response experiment showed that saturation of RNA synthesis is reached at a surprisingly low level of input RNA (5 g/ml; Fig. 2D ). Higher RNA concentrations (10 to 30 g/ml) markedly inhibited RNA synthesis. Also surprising was that this inhibition occurred at RNA concentrations which stimulated rather than inhibited viral translation (Fig. 1B) . A plausible explanation is that a viral protein(s), when accumulated to a certain level, can inhibit RNA replication. For example, RNA interaction with the structural proteins would engage it in a packaging complex and would preclude replication. Alternatively, EMCV RNA excess may sequester a host factor(s), which would facilitate RNA replication (3, 9) . It would be interesting to determine whether the negative-feedback mechanism for regulation of RNA replication by virus-specific products governs the switch from replication to encapsidation of the viral RNA in vivo.
After a 4-h incubation period, a small amount of 1B was evident in a protein-synthesizing reaction (Fig. 1A) , indicative of the final cleavage of 1AB, which accompanies virion morphogenesis (15) . To determine whether the EMCV RNA-pro- A 250-l translation reaction mixture was programmed with EMCV RNA for 20 h at 32°C and treated with the RNase A/T1 cocktail as described above. Triton X-100 was added to 0.5%, and the mixture was diluted to 5 ml with CsCl/phosphate-buffered saline (1.34 g/cm 3 solution density) (30) . The mixture was subjected to centrifugation at 45,000 rpm for 18 h at 6°C in a SW55 rotor. Fractions (0.25 ml) were collected and assayed for infectivity following serial dilutions. The arrow indicates the location of the virus formed in EMCV-infected Krebs-2 cells. (C) Time course of the infectivity titer of in vitro-synthesized EMCV. (D) Effect of creatine phosphate concentrations on EMCV yields. Reaction mixtures containing the indicated concentrations of creatine phosphate and 3.4 mM MgCl 2 were programmed with EMCV RNA for 20 h and assayed for infectivity as described above. In panels B, C, and D, programming was with 10 g of EMCV RNA/ml. (E) EMCV RNA dose response of virus yield. Reaction mixtures were programmed with the indicated concentrations of EMCV RNA for 20 h at 32°C, treated with RNase A/T1, and assayed for infectivity following serial dilutions. In panels C, D, and E, the data are averages (with standard deviations from the means) of three independent titer determinations. grammed reactions yield infectious virus, aliquots of translation samples withdrawn after 20 h of incubation were assayed for virus infectivity on BHK-21 cell monolayers. The in vitro reactions generated virus, and plaque morphologies were indistinguishable between in vitro-and in vivo-generated virus (Fig. 3A) . No plaques were detected in samples that were incubated at 0°C. Thus, infectivity of the agent generated in in vitro reactions is dependent on a temperature-sensitive process and cannot be accounted for by the presence of the infectious input RNA. CsCl gradient analysis demonstrated that the in vitro-generated infectious agent was associated with the characteristic buoyant density of mature cardiovirus particles (1.33 g/cm 3 ) (Fig. 3B ) (30) . To conclusively demonstrate the generation of intact virus particles, it is imperative to perform electron-microscopic examination. To this end, the peak fraction from the CsCl gradient (Fig. 3B ) was subjected to dialysis and concentration. These procedures, however, resulted in significant loss of virus, probably because of its adsorption to plastic surfaces (30) . Thus, electron-microscopic studies are not technically feasible now. Similar to RNA synthesis, EMCV production was more Mg 2ϩ concentration dependent than translation and was maximal at 3 to 3.5 mM MgCl 2 (data not shown). The infectivity of the in vitro-synthesized virus was already detectable between 2 and 4 h and reached maximum at 8 to 10 h of incubation (Fig. 3C) . Subsequent incubation somewhat decreased infectivity. We also found that raising the creatine phosphate level from 10 to 20 mM stimulated virus production more than threefold (up to 5 ϫ 10 7 to 6 ϫ 10 7 PFU/ml virus titer; Fig. 3D ), apparently by preventing the depletion of the nucleoside triphosphate pool (23) . Virus yield reached a maximum at 10 g of RNA/ml (Fig. 3E ). Higher RNA concentrations resulted in reduced virus synthesis, most likely because of the inhibition of RNA replication (Fig. 2D) .
PV replication both in vivo and in vitro occurs in association with membranes (6, 11, 22, 37) . Although not investigated in this study, it is likely that EMCV replication in vitro is also a membrane-dependent process. Indeed, we failed to show EMCV RNA replication and virus synthesis in a rabbit reticulocyte lysate (unpublished observations), which synthesizes EMCV proteins fairly well (25, 27) but is deficient in membranous structures compared to Krebs-2 S10 (5, 36, 38) .
In summary, we have described an efficient system for picornavirus synthesis. This system might be applicable to the studies of replication of pathogens other than EMCV. Indeed, PV synthesis was readily demonstrated in a Krebs-2 extract under conditions optimized for EMCV replication (unpublished observations). The system eliminates an important problem associated with cell membrane permeability and provides a means to study the effects of a wide spectrum of macromolecules and drugs on virus-specific processes.
